✓
Open
27 May 2025
✓
Close
29 May 2025
3
Allotment
—
✓
Listing
Tue, Jun 3, 2025
Price Band
₹128 to ₹135
Issue Size
27,90,000 shares (agg. up to ₹38 Cr)
Lot Size
1,000 Shares
Listing Date
Tue, Jun 3, 2025
✦ AI Insight
Live Subscription
| Category | Subscription (times) |
|---|---|
| Total | 2.10x |
Restated Financials (₹ Cr.)
| Period Ended | 31 Dec 2024 | 31 Mar 2024 | 31 Mar 2023 | 31 Mar 2022 |
|---|---|---|---|---|
| Assets | 96.52 | 80.89 | 64.28 | 52.91 |
| Total Income | 69.69 | 80.29 | 67.26 | 30.17 |
| Profit After Tax | 4.10 | 3.81 | 0.67 | 0.25 |
| NET Worth | 17.28 | 11.97 | 8.16 | 7.49 |
| Reserves and Surplus | 9.56 | 4.37 | 4.16 | 3.49 |
| Total Borrowing | 49.48 | 42.40 | 35.99 | 29.52 |
| Amount in ₹ Crore |
Peer Comparison
| Company | Issue Type | Issue Size | Issue Price | PE Ratio | Listing Day Close | Listing Gain/Loss % | LTP |
|---|---|---|---|---|---|---|---|
| Accretion Pharmaceuticals Ltd. | SME | ₹29.75 Cr | ₹101 | 21.29 | ₹82.95 | -17.87% | ₹210.00 |
| Amwill Health Care Ltd. | SME | ₹59.98 Cr | ₹111 | 13.81 | ₹93.25 | -15.99% | ₹43.51 |
| Sat Kartar Shopping Ltd. | SME | ₹33.80 Cr | ₹81 | 14.87 | ₹161.55 | +99.44% | ₹117.00 |
| Onyx Biotec Ltd. | SME | ₹29.34 Cr | ₹61 | 26.81 | ₹56.75 | -6.97% | ₹37.55 |
| Medicamen Organics Ltd. | SME | ₹10.54 Cr | ₹34 | 30.53 | ₹144.70 | +325.59% | ₹26.50 |
| Senores Pharmaceuticals Ltd. | Mainboard | ₹582.11 Cr | ₹391 | 39.77 | ₹557.80 | +42.66% | ₹1,509.80 |
| Sai Life Sciences Ltd. | Mainboard | ₹3,042.62 Cr | ₹549 | 126.42 | ₹764.65 | +39.28% | ₹1,647.10 |
| Akums Drugs & Pharmaceuticals Ltd. | Mainboard | ₹1,856.74 Cr | ₹679 | null | ₹796.25 | +17.27% | ₹736.60 |
| Emcure Pharmaceuticals Ltd. | Mainboard | ₹1,952.03 Cr | ₹1008 | 34.55 | ₹1,359.15 | +34.84% | ₹1,925.80 |
Objects of the Issue
| # | Issue Objects | Est Amt (₹ Cr.) |
|---|---|---|
| 1 | Funding of expenses proposed to be incurred towards registration in Bolivia, South America | 1.29 |
| 2 | Purchase and installation of plant and machineries for ointment production for the purpose of export in accordance with the international standards and protocols, on the 2nd floor of the Existing Premises | 5.23 |
| 3 | Advertising, marketing and brand building | 4.95 |
| 4 | Investment in procuring hardware and software | 0.68 |
| 5 | Funding of Working Capital Requirements | 19.75 |
| 6 | General Corporate Purposes | 1.99 |
| 7 | Issue Expenses | 3.77 |
| Total | 37.67 |
About Astonea Labs IPO
Updated on Aug 5, 2026
Contact Details
Astonea Labs Ltd. AddressSCO 186-187, 2nd Floor, Cabin No.206Sector 8 C, Sector 8Chandigarh, Chandigarh, 1600099888302323cs@astonea.orgVisit Website